View Author
scopus: 7202036428

Schouten, J.S.A.G.

(Jan S.A.G. Schouten)


patient treatment strategy glaucoma outcome value model health latanoprost decision cost-effectiveness parameter-speci fic evic therapy timolol medication study progression population analysis result effect blindness month target uncertainty ophthalmol attribute parameter-speci table simulation research parameter pressure analyses open-angle glaucoma treatment decision patient-level treatment strategies sensitivity evic framework target pressure distribution visit threshold patient-level attributes event hypertension calculation laser example ophthalmologica sensitivity analysis sensitivity analyses ophthalmology framework iop reduction university treatment strategy target iop reduction open-angle 30 mm hg information netherland heterogeneity policy utility surgery level difference life expectancy follow-up van gestel patient heterogeneity therapy adjustments disease appendix practice cataract progression rate




3 Most Recent Publications

Latanoprost versus timolol as first choice therapy in patients with ocular hypertension (Article)
Peeters, A. Schouten, J.S.A.G. Severens, J.L. Hendrikse, F. Prins, M. Webers, C.A.B.
2012-03-01
The long-term outcomes of four alternative treatment strategies for primary open-angle glaucoma (Article)
Gestel, A. van Webers, C.A.B. Severens, J.L. Beckers, H. Jansonius, N.M. Hendrikse, F. Schouten, J.S.A.G.
2012-02-01
The role of the expected value of individualized care in cost-effectiveness analyses and decision making (Article)
Gestel, A. van Grutters, J.C. Schouten, J.S.A.G. Webers, C.A.B. Beckers, H. Joore, M.A. Severens, J.L.
2012-01-01